Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clcc.2014.09.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Oxaliplatin-Induced Lhermitte's Sign in Gastric Cancer.
Case Rep Oncol Med
June 2020
Department of Gastroenterology, St. Luke's International Hospital, 9-1 Akashicho, Chuo-ku, Tokyo 104-8560, Japan.
A 64-year-old Japanese man with no significant medical history presented with epigastric discomfort of 2-weeks' duration. He was diagnosed with metastatic HER2-positive gastric cancer. Chemotherapy with capecitabine, oxaliplatin, and trastuzumab was initiated.
View Article and Find Full Text PDFOxaliplatin-induced Lhermitte sign. A case report and review of literature.
Clin Colorectal Cancer
December 2014
Division of Hematology and Oncology, West Michigan Cancer Center, Kalamazoo, MI. Electronic address:
Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity.
Oncology
March 2010
Prince of Wales Medical Research Institute and Prince of Wales Clinical School, Sydney, NSW, Australia.
Objectives: Lhermitte's phenomenon, characterized by 'electric-shock' sensations precipitated by neck flexion, may develop during oxaliplatin treatment. Limited cases have been described previously and the pathophysiology underlying Lhermitte's phenomenon in oxaliplatin-treated patients has not been established.
Methods: Patients who developed Lhermitte's phenomenon during oxaliplatin therapy were investigated by neurological examination, neurotoxicity grading and conventional nerve conduction studies (NCS).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!